Biochemical and molecular characterisation of neurological Wilson disease.

Go Hun SeoYoon-Myung KimSeak Hee OhSun Ju ChungIn Hee ChoiGu-Hwan KimMi-Sun YumJin-Ho ChoiKyung Mo KimTae-Sung KoBeom-Hee LeeHan-Wook Yoo

Published in: Journal of medical genetics (2018)

The neurological subgroup had distinct clinical, biochemical and genetic profiles. Further studies are required to identify the factors, with or without association with copper metabolism, underlying the neurological presentation for which treatment needs to be targeted to improve the clinical outcome of this subgroup.

Keyphrases

cerebral ischemia
randomized controlled trial
cancer therapy
blood brain barrier
brain injury
replacement therapy
open label
oxide nanoparticles
placebo controlled